Orpea SA

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: FR0000184798
EUR
13.01
-0.29 (-2.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

381.29 k

Shareholding (Dec 2023)

FII

0.00%

Held by 2 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Risky -

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 138.15%, its profits have fallen by -116.6%
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

EUR 2,163 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

3.02

stock-summary
Return on Equity

-17.46%

stock-summary
Price to Book

1.36

Revenue and Profits:
Net Sales:
378 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.42%
0%
8.42%
6 Months
15.34%
0%
15.34%
1 Year
138.15%
0%
138.15%
2 Years
-13.83%
0%
-13.83%
3 Years
101.33%
0%
101.33%
4 Years
-84.51%
0%
-84.51%
5 Years
-87.6%
0%
-87.6%

Orpea SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.70%
EBIT Growth (5y)
-21.10%
EBIT to Interest (avg)
0.28
Debt to EBITDA (avg)
19.40
Net Debt to Equity (avg)
2.94
Sales to Capital Employed (avg)
0.55
Tax Ratio
7.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.52%
ROE (avg)
24.60%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.48
EV to EBIT
64.47
EV to EBITDA
9.44
EV to Capital Employed
1.12
EV to Sales
1.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.74%
ROE (Latest)
-23.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Orpea SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.43% vs 11.04% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -130.54% vs 133.78% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,635.80",
          "val2": "5,197.80",
          "chgp": "8.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "696.90",
          "val2": "546.80",
          "chgp": "27.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "398.90",
          "val2": "581.70",
          "chgp": "-31.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "76.60",
          "val2": "-785.90",
          "chgp": "109.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-415.50",
          "val2": "1,360.70",
          "chgp": "-130.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.80%",
          "val2": "-23.20%",
          "chgp": "2.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5,635.80
5,197.80
8.43%
Operating Profit (PBDIT) excl Other Income
696.90
546.80
27.45%
Interest
398.90
581.70
-31.43%
Exceptional Items
76.60
-785.90
109.75%
Consolidate Net Profit
-415.50
1,360.70
-130.54%
Operating Profit Margin (Excl OI)
0.80%
-23.20%
2.40%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 8.43% vs 11.04% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -130.54% vs 133.78% in Dec 2023

stock-summaryCompany CV
About Orpea SA stock-summary
stock-summary
Orpea SA
Hospital
Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The Company operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. It operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
Company Coordinates stock-summary
Company Details
12 Rue Jean Jaures, Puteaux Cedex , PUTEAUX None : 92813
stock-summary
Tel: 33 1 47757807
stock-summary
Registrar Details